Sangamo Therapeutics (SGMOQ) Research & Development (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted Research & Development of $31.44 million for Q4 2025, up 32.8% from $23.68 million a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Research & Development (2010 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics' Research & Development came in at $112.67 million, up 1.0% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -9.0% (FY2020 to FY2025).
- In prior years, Sangamo Therapeutics' Research & Development was $111.52 million in FY2024 (-52.4%), $234.06 million in FY2023 (-6.3%), $249.9 million in FY2022 (+8.3%) and $230.82 million in FY2021 (+27.8%).
- The Q4 2025 figure stands as the highest quarterly Research & Development since Q1 2024.
- On a year-over-year basis, Research & Development has increased in each of the last three quarters, with an average decline of 23.9% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2021, with growth of 44.7%; the weakest was Q2 2024, with a decline of 61.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $28.14 million (Q3 2025), $27.08 million (Q2 2025) and $26.01 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Sangamo Therapeutics | 39.23 Mn | -74.88 Mn | - | 31.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 31.44 Mn |
| Sep 30, 2025 | 28.14 Mn |
| Jun 30, 2025 | 27.08 Mn |
| Mar 31, 2025 | 26.01 Mn |
| Dec 31, 2024 | 23.68 Mn |
| Sep 30, 2024 | 27.73 Mn |
| Jun 30, 2024 | 24.22 Mn |
| Mar 31, 2024 | 35.89 Mn |
| Dec 31, 2023 | 50.71 Mn |
| Sep 30, 2023 | 57.09 Mn |
| Jun 30, 2023 | 63.05 Mn |
| Mar 31, 2023 | 63.22 Mn |
| Dec 31, 2022 | 66.18 Mn |
| Sep 30, 2022 | 65.12 Mn |
| Jun 30, 2022 | 60.02 Mn |
| Mar 31, 2022 | 58.58 Mn |
| Dec 31, 2021 | 51.80 Mn |
| Sep 30, 2021 | 62.50 Mn |
| Jun 30, 2021 | 60.09 Mn |
| Mar 31, 2021 | 56.43 Mn |
API Access
Sangamo Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();